Condition
Idiopathic Hyperaldosteronism clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Idiopathic Hyperaldosteronism clinical trials that are recruiting, at sites in 2 countries (most in South Korea (1), China (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Targeted adrenal artery embolization versus oral spironolactone for idiopathic hyperaldosteronism
This trial will test whether a minimally invasive targeted adrenal artery embolization works as well as the oral drug spironolactone for people aged 15–60 with idiopathic hyperaldosteronism.
-
Using Gallium-68 Pentixafor PET-CT to improve surgery outcomes in primary aldosteronism
This trial will test whether adding gallium-68 pentixafor PET/CT to standard adrenal venous sampling helps people with primary aldosteronism have better results from adrenal surgery.
Related topics
Quick answers
How many Idiopathic Hyperaldosteronism clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in South Korea (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.